Both p38 MAPK inhibitors and COX-2 inhibitors have previously been shown to effectively reduce clinical signs of disease and paw swelling measurements in rodent models of arthritis [6,7,51,52]. The gene discussed is PTGS2; the disease is arthritic joint disease.